Dissolution Technologies

Papers
(The TQCC of Dissolution Technologies is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Study of Drug Release Kinetics of Rosuvastatin Calcium Immediate-Release Tablets Marketed in Saudi Arabia6
Update on Gastrointestinal Biorelevant Media and Physiologically Relevant Dissolution Conditions4
Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel4
In Vitro Biopharmaceutical Equivalence of Carbamazepine Sodium Tablets Available in Lima, Peru4
Development of In Vivo Predictive pH-Gradient Biphasic Dissolution Test for Weakly Basic Drugs: Optimization by Orthogonal Design3
Comparative Evaluation of In Vitro Drug Release Methods Employed for Nanoparticle Drug Release Studies3
Stimuli to the Revision Process: The Case for Apex Vessels2
In Vitro Solubility and Release Profile Correlation with pKa Value of Efavirenz Polymorphs2
Evaluation of NanoDis as an Automated Sampling Technology for In Vitro Release Testing of Nanomedicines2
Disintegration and Rupture Testing of Omega-3 Soft Capsules2
Effect of Mannitol Particle Size on Melatonin Dissolution and Tablet Properties using a Quality by Design Framework2
Comparative Dissolution of Budesonide from Four Commercially Available Products for Oral Administration: Implications for Interchangeablity2
Predictive Dissolution Models for Real-Time Release Testing: Development and Implementation - Workshop Summary Report2
In Vitro Biopharmaceutical Equivalence of 5-mg Glibenclamide Tabletsin Simulated Intestinal Fluid Without Enzymes2
A Data Set to Verify Volume and Sample Removal Correction Calculations for Dissolution Testing2
Predicting Dissolution of Entecavir Using the Noyes Whitney Equation1
Summary Report on Workshop on In Vitro Release Test (IVRT) and In Vitro Permeation Test (IVPT) Methods1
In-Vitro Product Performance of Parenteral Drug Products: View of the USP Expert Panel1
Comparative Assessment of Critical Quality Attributes of Sildenafil Tablets1
Simulated Lymphatic Fluid for In-Vitro Assessment in Pharmaceutical Development1
Biorelevant Dissolution Testing of Numerically Optimized Multiparticulate Drug Delivery Systems of Gliclazide1
Performance Tests – Update on USP Activities1
Development of In Vitro Dissolution Test Method for Bilastine and Montelukast Fixed-Dose Combination Tablets1
Highlights from the 2020 AAPS 360 Annual Meeting1
Dissolution Method Development for Regulatory Approval: A Comprehensive Review and Case Study1
Comparison of Generic Furosemide Products by In Vitro Release Studies using USP Apparatus 2 and 41
Quality Assessment of Brands of Prednisolone (5 Mg) Tablets Marketed in Abuja Metropolis of Nigeria1
Quality Attributes and In Vitro Bioequivalence of Amlodipine (5 mg) Tablets in Ica, Peru1
Role of Surfactants on Dissolution Behavior of Tamoxifen1
Biowaiver Study of Selected Solid Oral Prednisolone Products Available in Sri Lanka: Recommendations for Comparator Product Used in Biowaiver Testing1
Dissolution Best Practices and International Harmonization - AAPS Workshop Report1
Conventional Surfactants and a Model Based on Molecular Descriptors as Alternatives to the Drug Solubility in Fasted State Simulated Intestinal Fluid1
Advances in Product Quality and Performance Tests for Topical and Transdermal Products: View of the USP Expert Panel1
The Combination of Liqui-Mass System and Pelletization to Improve Pharmaceutical Properties of Hydrochlorothiazide1
In-Vitro Product Performance of Parenteral Drug Products: View of the USP Expert Panel1
Questions and Answers February 20211
0.048722982406616